Center for Complex Biological Systems, University of California, Irvine, Irvine, United States.
Department of Developmental and Cell Biology, University of California, Irvine, Irvine, United States.
Elife. 2020 Oct 13;9:e61026. doi: 10.7554/eLife.61026.
Mutational activation of the proto-oncogene in melanocytes reliably produces benign nevi (pigmented 'moles'), yet the same change is the most common driver mutation in melanoma. The reason nevi stop growing, and do not progress to melanoma, is widely attributed to a cell-autonomous process of 'oncogene-induced senescence'. Using a mouse model of Braf-driven nevus formation, analyzing both proliferative dynamics and single-cell gene expression, we found no evidence that nevus cells are senescent, either compared with other skin cells, or other melanocytes. We also found that nevus size distributions could not be fit by any simple cell-autonomous model of growth arrest, yet were easily fit by models based on collective cell behavior, for example in which arresting cells release an arrest-promoting factor. We suggest that nevus growth arrest is more likely related to the cell interactions that mediate size control in normal tissues, than to any cell-autonomous, 'oncogene-induced' program of senescence.
在黑素细胞中,原癌基因的突变激活可靠地产生良性痣(色素“痣”),然而,同样的变化是黑色素瘤中最常见的驱动突变。痣停止生长,不会进展为黑色素瘤的原因,通常归因于一种细胞自主的“癌基因诱导衰老”过程。使用一种由 Braf 驱动的痣形成的小鼠模型,分析增殖动力学和单细胞基因表达,我们发现与其他皮肤细胞或其他黑素细胞相比,痣细胞没有衰老的证据。我们还发现,痣的大小分布不能用任何简单的细胞自主生长抑制模型来拟合,但很容易用基于细胞集体行为的模型来拟合,例如,在这种模型中,静止的细胞释放出一种促进静止的因子。我们认为,痣的生长抑制可能与介导正常组织大小控制的细胞相互作用有关,而不是与任何细胞自主的“癌基因诱导”衰老程序有关。